Skip to main content
Log in

Association of HMOX-1 rs2071747 with sporadic Parkinson’s disease in southern Han Chinese

  • Original Article
  • Published:
Neurological Sciences Aims and scope Submit manuscript

Abstract

Study objectives.

To discover the associations between HMOX-1 and sporadic Parkinson’s disease (PD).

Methods

Five hundred sporadic PD patients and 500 healthy controls were recruited in this study. Polymerase chain reaction (PCR) was used.

Results

The dominant model of HMOX-1 rs2071747 was shown statistically significant between PD patients and control after adjustment of age and gender (dominant model: p value: 0.045, OR: 1.51, 95% CI: 1.01–2.27, adjusted). The associations of additive model and dominant model of rs2071747 were also found (additive model: p value: 0.047; dominant model: p value: 0.035, OR: 1.55, 95% CI: 1.03, 2.34).

Conclusions

We found the association of the dominant of HMOX1 rs2071747 with PD. We also found the associations of additive model and dominant model of HMOX1 rs2071747 with late onset PD (LOPD) patients.

Highlights

• The dominant model of HMOX1 rs2071747 was associated with PD.

• The additive model of HMOX1 rs2071747 was associated with LOPD.

• The dominant model of HMOX1 rs2071747 was associated with LOPD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

CI:

Confidence interval

EOPD:

Early onset Parkinson’s disease

HO-1:

Heme oxygenase-1

HWE:

Hardy-Weinberg equilibrium

LOPD:

Late onset Parkinson’s disease

MDS:

Movement disorders society

NCBI:

National Center for Biotechnology Information

OR:

Odds ratio

PCR:

Polymerase chain reaction

PD:

Parkinson’s disease

SNP:

Single nucleotide polymorphism

References

  1. Kalia LV, Lang AE (2015) Parkinson’s disease. Lancet 386(9996):896–912

    Article  CAS  Google Scholar 

  2. Li G et al (2019) Parkinson’s disease in China: a forty-year growing track of bedside work. Transl Neurodegener 8:22

    Article  CAS  Google Scholar 

  3. Ascherio A, Schwarzschild MA (2016) The epidemiology of Parkinson’s disease: risk factors and prevention. Lancet Neurol 15(12):1257–1272

    Article  Google Scholar 

  4. Masaldan S et al (2019) Striking while the iron is hot: iron metabolism and ferroptosis in neurodegeneration. Free Radical Biol Med 133:221–233

    Article  CAS  Google Scholar 

  5. García-Martín E et al (2015) Heme oxygenase-1 and 2 common genetic variants and risk for restless legs syndrome. Medicine 94(34):e1448–e1448

    Article  Google Scholar 

  6. Agúndez JAG et al (2016) Heme oxygenase-1 and 2 common genetic variants and risk for multiple sclerosis. Sci Rep 6:20830–20830

    Article  Google Scholar 

  7. Ayuso P et al (2014) An association study between heme oxygenase-1 genetic variants and Parkinson’s disease. Front Cell Neurosci 8:298

    Article  Google Scholar 

  8. Klingelhoefer L, Bhattacharya K, Reichmann H (2016) Restless legs syndrome. Clin Med (Lond) 16(4):379–382

    Article  Google Scholar 

  9. Postuma RB et al (2015) MDS clinical diagnostic criteria for Parkinson’s disease. Mov Disord 30(12):1591–1601

    Article  Google Scholar 

  10. Li G et al (2018) Association of GALC, ZNF184, IL1R2 and ELOVL7 With Parkinson’s Disease in Southern Chinese. Front Aging Neurosci 10:402

    Article  CAS  Google Scholar 

  11. Dupont WD, Plummer WD Jr (1990) Power and sample size calculations. A review and computer program. Control Clin Trials. 11(2):116–28

    Article  CAS  Google Scholar 

  12. Dupont WD, Plummer WD Jr (1998) Power and sample size calculations for studies involving linear regression. Control Clin Trials 19(6):589–601

    Article  CAS  Google Scholar 

  13. Schipper HM et al (2019) The sinister face of heme oxygenase-1 in brain aging and disease. Prog Neurobiol 172:40–70

    Article  CAS  Google Scholar 

  14. Park JS et al (2019) Neuroprotective effect of β-Lapachone in MPTP-induced Parkinson’s disease mouse model: involvement of astroglial p-AMPK/Nrf2/HO-1 signaling pathways. Biomol Ther (Seoul) 27(2):178–184

    Article  CAS  Google Scholar 

  15. Nitti M et al (2018) Heme oxygenase 1 in the nervous system: does it favor neuronal cell survival or induce neurodegeneration? Int J Mol Sci 19(8):2260

    Article  Google Scholar 

  16. Huang B et al (2018) α-Cyperone inhibits LPS-induced inflammation in BV-2 cells through activation of Akt/Nrf2/HO-1 and suppression of the NF-κB pathway. Food Funct 9(5):2735–2743

    Article  CAS  Google Scholar 

  17. Jeong YH et al (2019) Atractylodis Rhizoma Alba attenuates neuroinflammation in BV2 microglia upon LPS stimulation by inducing HO-1 activity and inhibiting NF-κB and MAPK. Int J Mol Sci 20(16):4015

    Article  CAS  Google Scholar 

  18. Cui B et al (2019) Farrerol attenuates β-amyloid-induced oxidative stress and inflammation through Nrf2/Keap1 pathway in a microglia cell line. Biomed Pharmacother 109:112–119

    Article  CAS  Google Scholar 

  19. Lane DJR, Ayton S, Bush AI (2018) Iron and Alzheimer’s disease: an update on emerging mechanisms. J Alzheimer Disease 64(s1):S379–S395

    Article  CAS  Google Scholar 

  20. Belaidi AA, Bush AI (2016) Iron neurochemistry in Alzheimer’s disease and Parkinson’s disease: targets for therapeutics. J Neurochem 139(Suppl 1):179–197

    Article  CAS  Google Scholar 

  21. Zucca FA et al (2017) Interactions of iron, dopamine and neuromelanin pathways in brain aging and Parkinson’s disease. Prog Neurobiol 155:96–119

    Article  CAS  Google Scholar 

  22. Ren J et al (2019) Tricetin protects against 6-OHDA-induced neurotoxicity in Parkinson’s disease model by activating Nrf2/HO-1 signaling pathway and preventing mitochondria-dependent apoptosis pathway. Toxicol Appl Pharmacol 378:114617

    Article  CAS  Google Scholar 

  23. Xu W et al (2017) Glaucocalyxin B alleviates lipopolysaccharide-induced Parkinson’s disease by inhibiting TLR/NF-κB and activating Nrf2/HO-1 pathway. Cell Physiol Biochem 44(6):2091–2104

    Article  CAS  Google Scholar 

  24. Mostile G et al (2017) Iron and Parkinson’s disease: a systematic review and meta-analysis. Mol Med Rep 15(5):3383–3389

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank all the patients who participated in this study.

Funding

This work was supported by grants from the National Natural Science Foundation of China 81601106 (to Ran Xiong).

the national natural science foundation of china,81601106,Ran Xiong

Author information

Authors and Affiliations

Authors

Contributions

Ran Xiong collected the PD and control data, performed the statistical analysis, and drafted the manuscript. Bei Zhang collected the PD data. Ran Xiong designed the study, supervised the study, double-checked the statistical analysis, and revised the manuscript.

Corresponding author

Correspondence to Ran Xiong.

Ethics declarations

Conflict of interest

The authors declare no competing interests.

Ethical approval

This study was approved by the ethic committee of East Hospital, Tongji University School of Medicine. There were no participants whose age was under 18 years old when we assess

Informed consent statement

All participants and their caregivers were fully informed. They signed written consent forms after informed.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Xiong, R., Zhang, B. Association of HMOX-1 rs2071747 with sporadic Parkinson’s disease in southern Han Chinese. Neurol Sci 43, 3671–3675 (2022). https://doi.org/10.1007/s10072-021-05830-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10072-021-05830-x

Keywords

Navigation